Reference
·Supporting source
DKSH and Zuellig Pharma Combined Distribution Reach
~60–70% of private-hospital procurement
DKSH Thailand and Zuellig Pharma Thailand together handle an estimated 60–70% of medical-device and pharmaceutical distribution to Thailand's private hospital sector. Both companies operate temperature-controlled warehousing, regulatory affairs teams, and direct-to-hospital sales forces. DKSH's healthcare segment in Thailand is disclosed within its Asia-Pacific business unit reports (DKSH Holding is listed on the SIX Swiss Exchange); Zuellig's Thailand financials are private. The private hospital segment — anchored by BDMS, Bangkok Chain, and Bumrungrad International — accounts for disproportionate device spending relative to public hospitals, which procure through the Government Pharmaceutical Organization (GPO) tender system.
Figure in context
DKSH Thailand and Zuellig Pharma Thailand together handle an estimated 60–70% of medical-device and pharmaceutical distribution to Thailand's private hospital sector. Both companies operate temperature-controlled warehousing, regulatory affairs teams, and direct-to-hospital sales forces. DKSH's healthcare segment in Thailand is disclosed within its Asia-Pacific business unit reports (DKSH Holding is listed on the SIX Swiss Exchange); Zuellig's Thailand financials are private. The private hospital segment — anchored by BDMS, Bangkok Chain, and Bumrungrad International — accounts for disproportionate device spending relative to public hospitals, which procure through the Government Pharmaceutical Organization (GPO) tender system.
DKSH Thailand and Zuellig Pharma Thailand together handle an estimated 60–70% of medical-device and pharmaceutical distribution to Thailand's private hospital sector. Both companies operate temperature-controlled warehousing, regulatory affairs teams, and direct-to-hospital sales forces. DKSH's healthcare segment in Thailand is disclosed within its Asia-Pacific business unit reports (DKSH Holding is listed on the SIX Swiss Exchange); Zuellig's Thailand financials are private. The private hospital segment — anchored by BDMS, Bangkok Chain, and Bumrungrad International — accounts for disproportionate device spending relative to public hospitals, which procure through the Government Pharmaceutical Organization (GPO) tender system.
Time scope
FY2023
Source basis
Supporting source
Interpretation notes
What this tells you
DKSH Thailand and Zuellig Pharma Thailand together handle an estimated 60–70% of medical-device and pharmaceutical distribution to Thailand's private hospital sector. Both companies operate temperature-controlled warehousing, regulatory affairs teams, and direct-to-hospital sales forces. DKSH's healthcare segment in Thailand is disclosed within its Asia-Pacific business unit reports (DKSH Holding is listed on the SIX Swiss Exchange); Zuellig's Thailand financials are private. The private hospital segment — anchored by BDMS, Bangkok Chain, and Bumrungrad International — accounts for disproportionate device spending relative to public hospitals, which procure through the Government Pharmaceutical Organization (GPO) tender system.
What not to do with it
Use the linked report for interpretation and keep basis differences explicit.
Related figures
Adjacent numbers that add context without drowning the value.
Thailand Medical Device Import Value
Thai FDA, Thai Customs Department, MOPH Annual Report
Thailand Medical Device Export Value
Thai Customs Department, THAIMED, BOI Thailand, Sri Trang Gloves Annual Report
JCI-Accredited Hospitals in Thailand
Joint Commission International, BDMS Annual Report, MOPH
Sri Trang Gloves Annual Production Capacity
Sri Trang Gloves Annual Report, THAIMED
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.